CTNNB1 mutations were associated with lower AFP levels (Rebouissou et al., 2016), indicating detection of CTNNB1 mutations may also have diagnostic value for HCC with atypical presentation. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.